Dongsheng Cheng1, Yang Fei1, Pierre-Jean Saulnier2,3,4, Niansong Wang5. 1. Department of Nephrology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, 200233, PR China. 2. Clinical Investigation Center CHU Poitiers, Poitiers, France. 3. Clinical Investigation Center CIC1402, INSERM, Poitiers, France. 4. Medical School, University of Poitiers, Poitiers, France. 5. Department of Nephrology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, 200233, PR China. wangniansong2012@163.com.
Abstract
PURPOSE: Inflammation plays an important role in the pathogenesis of diabetes complications. This study aims to assess the association between circulating inflammatory biomarkers TNF receptors (TNFRs) and the risk of renal disease progression, cardiovascular disease (CVD) events, and mortality in patients with diabetes. METHODS: PubMed and Embase databases were comprehensively searched up to March 2019. Data were extracted independently by two reviewers. A random effects model was performed for the pooled analyses. RESULTS: Five studies in 3316 subjects assessed TNFRs with renal disease in patients with type 1 diabetes and showed both TNFR-1 and TNFR-2 were consistently associated with the renal outcomes. Fourteen studies in 7696 subjects evaluated TNFRs in patients with type 2 diabetes. The pooled risk ratio per doubling increase in TNFR-1 and TNFR-2 for renal disease progression was more than two (2.64 [1.98, 3.52] and 2.23 [1.69, 2.94]). The subgroup analyses and sensitivity analyses further illustrated these results of renal outcome and its robustness. Moreover, higher TNFR-1 and TNFR-2 was also significantly associated with CVD events and mortality in patients with type 2 diabetes. CONCLUSIONS: Circulating TNFR-1 and TNFR-2 are independently associated with higher risk of renal disease progression, CVD events, and mortality in patients with diabetes and might contribute to the clinical risk assessment in the future.
PURPOSE: Inflammation plays an important role in the pathogenesis of diabetes complications. This study aims to assess the association between circulating inflammatory biomarkers TNF receptors (TNFRs) and the risk of renal disease progression, cardiovascular disease (CVD) events, and mortality in patients with diabetes. METHODS: PubMed and Embase databases were comprehensively searched up to March 2019. Data were extracted independently by two reviewers. A random effects model was performed for the pooled analyses. RESULTS: Five studies in 3316 subjects assessed TNFRs with renal disease in patients with type 1 diabetes and showed both TNFR-1 and TNFR-2 were consistently associated with the renal outcomes. Fourteen studies in 7696 subjects evaluated TNFRs in patients with type 2 diabetes. The pooled risk ratio per doubling increase in TNFR-1 and TNFR-2 for renal disease progression was more than two (2.64 [1.98, 3.52] and 2.23 [1.69, 2.94]). The subgroup analyses and sensitivity analyses further illustrated these results of renal outcome and its robustness. Moreover, higher TNFR-1 and TNFR-2 was also significantly associated with CVD events and mortality in patients with type 2 diabetes. CONCLUSIONS: Circulating TNFR-1 and TNFR-2 are independently associated with higher risk of renal disease progression, CVD events, and mortality in patients with diabetes and might contribute to the clinical risk assessment in the future.
Authors: Tomohito Gohda; Monika A Niewczas; Linda H Ficociello; William H Walker; Jan Skupien; Florencia Rosetti; Xavier Cullere; Amanda C Johnson; Gordon Crabtree; Adam M Smiles; Tanya N Mayadas; James H Warram; Andrzej S Krolewski Journal: J Am Soc Nephrol Date: 2012-01-19 Impact factor: 10.121
Authors: Monika A Niewczas; Tomohito Gohda; Jan Skupien; Adam M Smiles; William H Walker; Florencia Rosetti; Xavier Cullere; John H Eckfeldt; Alessandro Doria; Tanya N Mayadas; James H Warram; Andrzej S Krolewski Journal: J Am Soc Nephrol Date: 2012-01-19 Impact factor: 10.121
Authors: Edward W Gregg; Xiaohui Zhuo; Yiling J Cheng; Ann L Albright; K M Venkat Narayan; Theodore J Thompson Journal: Lancet Diabetes Endocrinol Date: 2014-08-12 Impact factor: 32.069
Authors: Steven G Coca; Girish N Nadkarni; Yuan Huang; Dennis G Moledina; Veena Rao; Jane Zhang; Bart Ferket; Susan T Crowley; Linda F Fried; Chirag R Parikh Journal: J Am Soc Nephrol Date: 2017-05-05 Impact factor: 10.121
Authors: Carol Forsblom; John Moran; Valma Harjutsalo; Tony Loughman; Johan Wadén; Nina Tolonen; Lena Thorn; Markku Saraheimo; Daniel Gordin; Per-Henrik Groop; Merlin C Thomas Journal: Diabetes Care Date: 2014-05-30 Impact factor: 19.112
Authors: Taha Sen; Jingwei Li; Brendon L Neuen; Bruce Neal; Clare Arnott; Chirag R Parikh; Steven G Coca; Vlado Perkovic; Kenneth W Mahaffey; Yshai Yavin; Norman Rosenthal; Michael K Hansen; Hiddo J L Heerspink Journal: Diabetologia Date: 2021-08-20 Impact factor: 10.122
Authors: Daniel Sepúlveda-Crespo; Norma Rallón; María José Muñoz-Gómez; Oscar Brochado-Kith; José Luis Jiménez; María Ángeles Muñoz-Fernández; José M Benito; Salvador Resino Journal: Front Cell Infect Microbiol Date: 2022-03-17 Impact factor: 5.293
Authors: Faten A AlRadini; Azza A K El-Sheikh; Abeer S Al Shahrani; Norah M Alzamil; Amel A Fayed; Eman Alsayed; Shatha S Alharbi; Msaad A Altulihee; Shaimaa A Andijani; Wafa K AlShaiddi; Fahad A Alamri Journal: Int J Gen Med Date: 2022-09-05